Skip to main content

Celcuity LLC (CELC) Stock

Celcuity LLC Stock Details, Movements and Public Alerts

Stock Details

Celcuity LLC (CELC), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $114.22. Over the past 52 weeks, it has ranged between $7.58 and $120.31. This places the current price at 94.9% of its 52-week high and 1406.9% above its 52-week low. Recent trading volume was recorded at 434,725. The 14-day Relative Strength Index (RSI) stands at 58.42, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $106.76 by 6.99%. Similarly, it is above its 200-day moving average of $63.50 by 79.87%. The MACD histogram is 0.39, indicating bullish momentum (MACD Line: 0.83, Signal Line: 0.44).

52-Week Range

$120.31 - $7.58

-5.06% from high · +1406.86% from low

Avg Daily Volume

632,322

20-day average

100-day avg: 921,179

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

45.19

EV/EBITDA

-7.80

EPS (TTM)

-$3.68

Beta

0.41

Less volatile than market

Q:How is CELC valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is CELC's risk profile compared to the market?
With a beta of 0.41, Celcuity LLC is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 45.19 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-159,268,000

Return on Equity

-122.00%

Return on Assets

-26.60%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is CELC's business model?
Profitability metrics are not available for this stock.
Q:What are CELC's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$5.3B

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

46.27M

Book Value/Share

$2.70

Asset Type

Common Stock

Q:What is CELC's market capitalization and position?
Celcuity LLC has a market capitalization of $5.3B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 46.27M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does CELC's price compare to its book value?
Celcuity LLC's book value per share is $2.70, while the current stock price is $114.22, resulting in a price-to-book (P/B) ratio of 42.26. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$119.40

4.54% upside potential

Analyst Recommendations

Strong Buy

1

Buy

9

Hold

1

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for CELC?
11 analysts cover CELC with 91% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $119.40 implies 4.5% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on CELC?
Current analyst recommendations:1 Strong Buy, 9 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 15, 2026, 02:49 AM

Technical Indicators

RSI (14-day)

58.42

Neutral

50-Day Moving Average

$106.76

6.99% above MA-50

200-Day Moving Average

$63.50

79.87% above MA-200

MACD Line

0.83

MACD Signal

0.44

MACD Histogram

0.39

Bullish

Q:What does CELC's RSI value tell investors?
The RSI (Relative Strength Index) for CELC is currently 58.42, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret CELC's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.83 above the signal line at 0.44, with histogram at 0.39. This bullish crossover suggests upward momentum is building. The 50-day MA ($106.76) is above the 200-day MA ($63.50), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 5, 2026, 12:41 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for CELC and get notified when the price changes.

Stay Ahead of the Market with Celcuity LLC Alerts

Set up price alerts for Celcuity LLC and get notified instantly when the price hits your target. Never miss an important price movement again.